Preoperative neutrophil-to-lymphocyte ratio and tumor-related factors to predict lymph node metastasis in nonfunctioning pancreatic neuroendocrine tumors

被引:17
|
作者
Zhou, Bo [1 ]
Deng, Junfang [1 ]
Chen, Lifeng [2 ]
Zheng, Shusen [1 ]
机构
[1] Zhejiang Univ, Sch Med,Minist Publ Hlth, Key Lab Combined Multiorgan Transplantat,Affiliat, Dept Hepatobiliary Pancreat Surg,Key Lab Organ Tr, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Med Engn Dept, Hangzhou, Zhejiang, Peoples R China
来源
SCIENTIFIC REPORTS | 2017年 / 7卷
基金
中国国家自然科学基金;
关键词
SURVIVAL; CANCER; LYMPHADENECTOMY; RESECTION; IMPACT;
D O I
10.1038/s41598-017-17885-y
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The lymph node (LN) status is very important for the survival in pancreatic neuroendocrine tumors (PNETs). Therefore, the investigation of factors related to LN metastases has a great clinical significance. The aim of this study was to evaluate the predictive value of the preoperative neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and possible clinical parameters on the LN metastases in nonfunctional PNETs (NF-PNETs). A retrospective review of 101 NF-PNET patients following curative resection and lymphadenectomy was conducted. The associations between clinicopathological factors and LN metastases and prognosis were determined. Twenty-seven (26.7%) patients had LN metastases. LN metastases was independently associated with disease-free survival (P = 0.009). Ideal cutoff values for predicting LN metastases were 1.80 for NLR, 168.25 for PLR and 2.5 cm for tumor size according to the receiver operating characteristic curve. On multivariable analysis, NLR (P = 0.017), symptomatic diagnosis (P = 0.028) and tumor size (P = 0.020) were associated with LN metastases. These results indicate that preoperative NLR = 1.80, tumor size = 2.5 cm and symptomatic diagnosis are independently associated with LN metastases for patients undergoing resection of NF-PNETs. It is anticipated that these findings are useful for further planning of lymphadenectomy before surgery.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Preoperative Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio Cannot Predict Lymph Node Metastasis and Prognosis in Patients with Early Gastric Cancer:a Single Institution Investigation in China
    朱光胜
    田少博
    王辉
    麻懋光
    刘亚
    杜寒松
    龙跃平
    Current Medical Science, 2018, 38 (01) : 78 - 84
  • [42] Preoperative Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio Cannot Predict Lymph Node Metastasis and Prognosis in Patients with Early Gastric Cancer: a Single Institution Investigation in China
    Guang-sheng Zhu
    Shao-bo Tian
    Hui Wang
    Mao-guang Ma
    Ya Liu
    Han-song Du
    Yue-ping Long
    Current Medical Science, 2018, 38 : 78 - 84
  • [43] Preoperative Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio Cannot Predict Lymph Node Metastasis and Prognosis in Patients with Early Gastric Cancer: a Single Institution Investigation in China
    Zhu, Guang-sheng
    Tian, Shao-bo
    Wang, Hui
    Ma, Mao-guang
    Liu, Ya
    Du, Han-song
    Long, Yue-ping
    CURRENT MEDICAL SCIENCE, 2018, 38 (01) : 78 - 84
  • [44] Relationship Between Lymph Node Metastasis and Lymph Node Density and Preoperative Neutrophil-Lymphocyte Ratio in Patients Undergoing Radical Cystectomy
    Kolukcu, Engin
    Atilgan, Dogan
    Kuyucu, Yunus Emre
    Ozbek, Latif Mustafa
    Unsal, Velid
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2021, 20 (03): : 168 - 173
  • [45] Preoperative neutrophil-to-lymphocyte ratio (preNLR) for the assessment of tumor characteristics in lung adenocarcinoma patients with brain metastasis
    Cui, Huanhuan
    Yang, Yuechao
    Feng, Mingtao
    Gao, Yang
    Li, Liangdong
    Tu, Wenjing
    Chen, Xin
    Hao, Bin
    Li, Sen
    Li, Deheng
    Chen, Lei
    Zhou, Changshuai
    Cao, Yiqun
    TRANSLATIONAL ONCOLOGY, 2022, 22
  • [46] Preoperative neutrophil-to-lymphocyte ratio (NLR) predicts recurrence after surgery in patient with pancreatic neuroendocrine neoplasm (PanNEN)
    Miura, T.
    Aoki, T.
    Ohtsuka, H.
    Aoki, S.
    Hata, T.
    Iseki, M.
    Takadate, T.
    Ariake, K.
    Kawaguchi, K.
    Masuda, K.
    Ishida, M.
    Mizuma, M.
    Hayashi, H.
    Nakagawa, K.
    Morikawa, T.
    Motoi, F.
    Sasano, H.
    Naitoh, T.
    Kamei, T.
    Unno, M.
    ANNALS OF ONCOLOGY, 2019, 30
  • [47] Prognostic Value of Neutrophil-to-Lymphocyte Ratio (NLR) in Intestinal Neuroendocrine Tumors: An Analysis of the US Neuroendocrine Tumor Study Group
    Krasnick, B. A.
    Davidson, J.
    Panni, R. Z.
    McGilvray, M.
    Rodriguez, J.
    Lopez-Aguiar, A. G.
    Dillhoff, M.
    Beal, E. W.
    Poultsides, G.
    Makris, E. A.
    Rocha, F. G.
    Crown, A.
    Idrees, K.
    Smith, P. M.
    Cho, C. S.
    Beems, M.
    Weber, S.
    Fisher, A.
    Hawkins, W.
    Strasberg, S. M.
    Hammill, C.
    Chapman, W.
    Doyle, M. B.
    Maithel, S. K.
    Fields, R.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : S152 - S152
  • [48] Development and validation of nomogram to predict lymph node metastasis preoperatively in patients with pancreatic neuroendocrine tumor
    Huang, Xi-Tai
    Xie, Jin-Zhao
    Huang, Chen-Song
    Li, Jian-Hui
    Chen, Wei
    Liang, Li-Jian
    Yin, Xiao-Yu
    HPB, 2022, 24 (12) : 2112 - 2118
  • [49] The preoperative neutrophil-to-lymphocyte ratio predictive value for survival in patients with brain metastasis
    Picarelli, Helder
    Yamaki, Vitor Nagai
    Fontoura Solla, Davi Jorge
    Neville, Iuri Santana
    dos Santos, Alexandra Gomes
    Amaral Garcia de Freitas, Bruno Spindola
    Diep, Calvin
    Paiva, Wellingson Silva
    Teixeira, Manoel Jacobsen
    Figueiredo, Eberval Gadelha
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2022, 80 (09) : 922 - 928
  • [50] The Neutrophil-to-Lymphocyte Ratio as a Marker of Lymph Node Status in Patients with Rectal Cancer
    Khan, Aftab A.
    Akritidis, Georgios
    Pring, Toby
    Alagarathnam, Swethan
    Roberts, Geoffrey
    Raymond, Regina
    Varcada, Massimo
    Novell, Richard
    ONCOLOGY, 2016, 91 (02) : 69 - 77